Samsung Biologics to manufacture Moderna’s mRNA-1273 COVID-19 vaccine

Samsung Biologics to manufacture Moderna’s mRNA-1273 COVID-19 vaccine

Moderna has signed a manufacturing services and supply agreement with Samsung Biologics under which the latter will undertake large scale, commercial fill-finish manufacturing for the mRNA-1273 COVID-19 vaccine. According to Samsung Biologics, technology transfer will begin immediately at the company’s facilities in Incheon, South Korea. The South Korean CDMO will use a production line equipped […]

US FDA authorizes Moderna Covid-19 vaccine mRNA-1273

US FDA authorizes Moderna Covid-19 vaccine mRNA-1273

Moderna Covid-19 vaccine : The US Food and Drug Administration (FDA) has given emergency use authorization (EUA) for mRNA-1273, the messenger RNA (mRNA) Covid-19 vaccine candidate of Moderna. The FDA authorization is for the use of mRNA-1273 in individuals aged 18 years and more for the prevention of Covid-19 caused by severe acute respiratory syndrome […]

COVID-19 vaccine trials : Research Centers of America begins enrollment of healthy volunteers

COVID-19 vaccine trials : Research Centers of America begins enrollment of healthy volunteers

Research Centers of America (RCA), an independent research site in  Broward County, Florida, said that it is currently holding COVID-19 vaccine trials, implemented under the US government’s Operation Warp Speed (OWS). The research site is enrolling volunteers to take part in the clinical trials, working with the US government and various pharma companies, which have developed […]

Moderna, Rovi to collaborate on fill-finish manufacturing of mRNA-1273

Moderna, Rovi to collaborate on fill-finish manufacturing of mRNA-1273

Moderna and Laboratorios Farmacéuticos Rovi have entered into a collaboration for large-scale, commercial fill-finish manufacturing of mRNA-1273, the former’s mRNA vaccine candidate against COVID-19, at the latter’s facility in Madrid, Spain. Under the agreement terms, ROVI will offer vial filling and packaging capacity by procuring a new production line and equipment for compounding, filling, automatic […]

Coronavirus vaccine trial : Moderna doses first subject with mRNA-1273 in phase 1 trial

Coronavirus vaccine trial : Moderna doses first subject with mRNA-1273 in phase 1 trial

Coronavirus vaccine trial : US biotech company Moderna has dosed the first participant in the phase 1 study of mRNA-1273, its mRNA vaccine against the novel coronavirus (SARS-CoV-2). The phase 1 coronavirus clinical trial is being carried out under its own Investigational New Drug (IND) application by the National Institutes of Health (NIH). mRNA-1273 is […]